Photos et vidéos issues de nos recherches.
Our research on oxytocin as potential treatment of tantrums highlighted by Happiest Health news
https://www.happiesthealth.com/articles/neurology/social-fear-in-asd
New multicentric study on the vulnerability to depression and resistance to treatment starting in 2024. We are recruiting postdocs and PhD students
Our research on vasopressin as potential treatment of autism highlighted by Spectrum News https://www.spectrumnews.org/news/vasopressin-relieves-social-deficits-in-an-autism-mouse-model/
Amelie Borie. Prix de la SNE 2021. Correction of vasopressin deficit in the lateral septum ameliorates social deficits of mouse autism model https://www.neuroendocrinologie.fr/type_de_prix_ou_bourse/prix-de-la-sne/
Our research selected as high impact 2019 by the societe des neurosciences for the discovery of the cognitive signaling of stress https://www.pnas.org/doi/abs/10.1073/pnas.1903203116?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
Our research selected as high impact 2019 by the societe de neuroendocrinologie fir the discovery of the cognitive signaling of stress https://www.pnas.org/doi/abs/10.1073/pnas.1903203116?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
Our research on the cerebrovascular pathology of Alzheimer’s disease is making the cover of the Journal Neurobiology of disease https://www.sciencedirect.com/science/article/abs/pii/S0969996116300018?via%3Dihub
Our research on the genetic programmation of mitochondrial fitness is making the cover of the Journal of Neuroscience
Our research on the cognitive signaling of stress and antidepressant response is making the cover of PNAS
Freddy Jeanneteau is the recipient of the medical prize Jean Valade 2014 for his discoveries on the menomic effects of stress
Freddy Jeanneteau is laureate of the starting grant ATIP-AVENIR 2013